CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS (Unaudited) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023
Revenues:
Grant revenue	$ 4,180	$ 1,928	$ 9,243	$ 3,258
Collaboration revenue - related party	5,903	519	9,967	1,036
Collaboration revenue	$ 114	$ 269	$ 254	$ 492
Type of Revenue [Extensible List]	us-gaap:LicenseMember	us-gaap:LicenseMember	us-gaap:LicenseMember	us-gaap:LicenseMember
Total revenues	$ 10,197	$ 2,716	$ 19,464	$ 4,786
Operating expenses:
Research and development	23,725	9,510	41,057	18,489
General and administrative	5,533	6,096	11,450	13,413
Total operating expenses	29,258	15,606	52,507	31,902
Loss from operations	(19,061)	(12,890)	(33,043)	(27,116)
Other income (expense):
Interest income	1,198	982	2,525	1,944
Other income (expense), net	1	(6)	(13)	(8)
Total other income (expense), net	1,199	976	2,512	1,936
Net loss and comprehensive loss	$ (17,862)	$ (11,914)	$ (30,531)	$ (25,180)
Net loss per share attributable to common stockholders, basic	$ (0.33)	$ (0.23)	$ (0.57)	$ (0.48)
Net loss per share attributable to common stockholders, diluted	$ (0.33)	$ (0.23)	$ (0.57)	$ (0.48)
Weighted average common shares outstanding, basic	53,957,766	52,571,813	53,740,901	52,549,538
Weighted average common shares outstanding, diluted	53,957,766	52,571,813	53,740,901	52,549,538